Researchers Unlock New Clues to Why Group A Strep Bacteria Targets Humans
Posted on: Monday, 6 December 2004, 18:00 CST
SAN DIEGO, Dec. 6 /PRNewswire/ -- Researchers have unlocked new clues in understanding why group A streptococci (GAS) has a range of bacterial afflictions in humans. One of the keys to this species of bacteria is its production of streptokinase (SK), an enzyme that activates plasminogen, the blood clot-dissolving protein in humans.
Findings of the research will be presented today at the 46th Annual Meeting of the American Society of Hematology (ASH). Results of the study suggest that GAS, a group of bacterial organisms that cause a range of infectious diseases, from those as common as strep throat to the wildly virulent and often fatal "flesh-eating" bacterium, attacks soft tissues and internal organs and spreads through the blood stream and surrounding tissues by breaking down the barriers created by local blood clots that could contain the infection.
Streptokinase produced by GAS that infect humans is highly specific for human plasminogen (PLG) and has little or no effect in other mammals. Generating a humanized transgenic mouse that expressed human PLG, the researchers tested for the specificity of the interaction with GAS. When the mice were introduced to GAS they were highly susceptible to infection and mortality was higher compared with the normal mice. The increased susceptibility of mice to GAS, however, was largely abrogated when the SK gene was deleted, leading the researchers to identify the major role of the PLG/SK interaction in the GAS pathogenicity.
"While we don't know exactly why the same bacterium causes such a range of illnesses from mild and harmless to life threatening, our study provides new clues that begin to unlock this mystery," according to Hongmin Sun, Ph.D., University of Michigan Medical School, and lead author of the study. "Most notably, our observations highlight the potential role of infectious disease as a critical force in the evolution of the hemostatic system and the unusual species specificity of many coagulation factor interactions."
The American Society of Hematology (http://www.hematology.org/) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
American Society of Hematology
CONTACT: Kara Vonasek of Spectrum Science, +1-202-955-6222,kvonasek@spectrumscience.com, for American Society of Hematology; or AislinnRaedy of American Society of Hematology, +1-202-776-0544,araedy@hematology.org; On-site (12.4-12.7): +1-619-525-6205
Web site: http://www.hematology.org/
Source: PRNewswire
Related Articles
- Ground-Breaking Human Study On the Effects of TASER Electronic Control Devices Published in Peer-Reviewed Journal of the Society of Academic Emergency Medicine
- ProMetic Announces Octapharma Publication of PRDT's Prion Removal Resin in Octaplas(R) Manufacturing Process at 30th International Congress of the International Society for Blood Transfusion Meeting in Macao SAR, China
- Cerus Announces Major Presence at Upcoming International Society of Blood Transfusion Conference
- Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
- DNAPrint Announces German Business Partner's First Human Study of Product to Prevent Migraines
- I-Flow Corporation Announces That a Human Study is Underway in Colorectal Surgery to Evaluate Antimicrobial Benefits of ON-Q(R)
- H. Lee Moffitt Cancer Center and Inovio Biomedical Announce Positive Results From Pioneering Human Study of Plasmid DNA Delivery Using Electroporation
- Human Study Shows Protandim(R) Provides a Fundamentally New Approach to Antioxidant Therapy
- InSightec Announces Enrollment of African American Women in FDA PostMarketing Study
- Obesity and Renal Transplant Outcome: A Report of the North American Pediatric Renal Transplant Cooperative Study
 |
 |
User Comments (0)
RSS Feeds